7 completed. 5 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Reckitt Benckiser Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h Mucinex® - Healthy Subjects | Phase 1 | Completed | Reckitt Benckiser Inc. | 30 | 2013-06-02 | 2019-06-17 |
| Mucinex Exploratory Cold Study guaifenesin (Mucinex), placebo - Common Cold | Phase 2 | Completed | Reckitt Benckiser Inc. | 378 | 2009-12-01 | 2020-12-30 |
| Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI Guaifenesin, Placebo - Acute Upper Respiratory Track Infection | Phase 4 | Completed | Reckitt Benckiser Inc. | 1179 | 2009-10-01 | 2020-12-30 |
| Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers. Vicks Cough Syrup for Chesty Coughs, Robitussin Extra Strength Chest Congestion, Organ-I- NR tablet - Healthy Subjects | Phase 1 | Completed | Reckitt Benckiser Inc. | 30 | 2009-06-30 | 2019-03-27 |
| Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers Mucinex® ER 600 mg - Healthy Subjects | Phase 1 | Completed | Reckitt Benckiser Inc. | 30 | 2009-06-04 | 2019-02-28 |
| Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung Mucinex 1200mg, Placebo - Mucociliary Clearance | Phase 1 | Completed | University of North Carolina, Chapel Hill | 12 | 2009-05-01 | 2012-06-11 |
| Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers Mucinex® SE, Vicks Cough Syrup for Chesty Coughs - Healthy Subjects | Phase 1 | Completed | Reckitt Benckiser Inc. | 30 | 2009-01-16 | 2019-06-19 |
Common Cold (1)
Guaifenesin (5) · Acetylcysteine (4) · Amiloride (1) · Pseudoephedrine (1)
United States (3)